MedPath

Management of Garbhini Chardi (Emesis Gravidarum) thrrough ayurveda.

Phase 2
Conditions
Health Condition 1: O210- Mild hyperemesis gravidarum
Registration Number
CTRI/2023/07/054944
Lead Sponsor
Dr Sahil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Subjects having confirm diagnosis of pregnancy.

2 Subjects presenting the classical symptoms of Garbhini chardi.

3 Subjects presenting with symptoms of Emesis Gravidarum.

4 Patients of age group between 20 to 40 years.

5 All patient diagnosed with chardi during pregnancy (both primi and muitigravida)

Exclusion Criteria

1 Subjects with Hyperemesis Gravidarum.

2 vomiting caused due to ectopic pregnancy and vesicular mole.

3 Vomiting caused due to any medical and surgical condition.

4 Vomiting caused due to Red degeneration fibroid, Twisted Ovarian Tumor

5 Patient with PIH (pregnancy induced hypertension), GDM (gestational diabetes mellitus) and High-risk pregnancies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate the efficacy of Eladi Choorna in management of Garbhini Chardi w.s.r. Emesis Gravidarum. <br/ ><br>2.Improvement in subjective and objective criteria of patient.Timepoint: Duration of Treatment -It will be given for 60 days <br/ ><br>Follow up: It will be done on 8th, 15th and 30th Day during treatment and reassessment will be done after every 15 days for 1 month .
Secondary Outcome Measures
NameTimeMethod
1. To study the garbhini chardi in diffrent ayurvedic text & correlate it with Emesis Gravidarum. <br/ ><br>2. To find out an ayurvedic approach for the management of Garbhini Chardi.Timepoint: Duration of Treatment -It will be given for 60 days <br/ ><br>Follow up: It will be done on 8th, 15th & 30th Day during treatment & reassessment will be done after every 15 days for 1 month.
© Copyright 2025. All Rights Reserved by MedPath